Your browser doesn't support javascript.
loading
LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer.
Zhang, Peng; Xie, Xiaodu; Li, Chunming; Zhang, Chaohua; Liang, Peihe.
Affiliation
  • Zhang P; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Xie X; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Li C; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Zhang C; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Liang P; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Cancer Med ; 12(19): 19758-19776, 2023 10.
Article in En | MEDLINE | ID: mdl-37706625
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Country of publication: